A cancer diagnosis is one of the most feared events. Rarely diagnosed before the late
twentieth century, cancer now competes with cardiovascular disease as the leading cause of …

Background Current guidelines set out when to start anticancer treatments, but not when to
stop as the end of life approaches. Conventional cytotoxic agents are administered …

Cancer costs continue to increase alarmingly despite much debate about how they can be
reduced. The oncology community needs to take greater responsibility for our own practice …

Purpose The purpose of this study was to investigate and compare cancer treatment near
the end-of-life (EOL) over a 10-year period. Materials and Methods Patients with advanced …

Importance Significant controversy exists regarding whether physicians factor personal
financial considerations into their clinical decision making. Within oncology, several …

Background. Many cancer patients receive chemotherapy and radiotherapy their last 30
days [end of life (EOL)]. The benefit is questionable and side effects are common. The aim of …

Purpose: To examine the long-term trends in medical oncology outreach in Iowa, a state with
a high proportion of rural residents, and to assess the involvement of the 2011 Iowa …

Disease-directed therapy near death is a growing trend among persons living with late-
stage cancer. As a sociocultural phenomenon, cancer-directed therapy (eg, chemotherapy) …

We investigate the role of physician agency in determining health care supply and patient
outcomes. We show that an increase in health care supply due to a change in private …

Cessation of chemotherapy in the last few weeks of life could be an important quality‐of‐
care benchmark. Proportion of metastatic breast cancer patients who receive end‐of‐life …